Personalis (PSNL) Cash from Financing Activities (2018 - 2026)
Personalis (PSNL) posted quarterly Cash from Financing Activities of $17.8 million for Q1 2026, down 11.24% year-over-year from $20.1 million in Q1 2025, and down 83.92% quarter-over-quarter from $110.9 million in Q4 2025.
Personalis (PSNL) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Personalis' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $17.8 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 11.24% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $128.1 million (down 4.15% YoY), while the FY2025 annual figure was $130.3 million, up 13.66% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $17.8 million, down from $110.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $110.9 million in Q4 2025, with the low at -$420000.0 in Q2 2022.
- The 5-year median for Cash from Financing Activities is $1.1 million (2024), against an average of $18.3 million.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 21426.21% in 2024, then slumped 121.57% in 2025.
- Personalis' Cash from Financing Activities stood at $511000.0 in 2022, then surged by 1820.94% to $9.8 million in 2023, then soared by 405.31% to $49.6 million in 2024, then jumped by 123.57% to $110.9 million in 2025, then slumped by 83.92% to $17.8 million in 2026.
- Business Quant data shows PSNL's Cash from Financing Activities at $17.8 million in Q1 2026, $110.9 million in Q4 2025, and -$317000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Personalis | 1.78 Bn | 1.56 Bn | 4.74 Mn | 7.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.99 Mn |
| Jun 30, 2026 | 7.99 Mn |
| Mar 31, 2026 | 17.83 Mn |
| Mar 31, 2026 | 17.83 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Mar 31, 2025 | 20.09 Mn |
| Mar 31, 2025 | 20.09 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |